Cargando…

Clinicopathological characteristics of early onset colorectal cancer

BACKGROUND: The rising incidence of early onset colorectal cancer (EOCRC) might reflect a novel tumour entity. AIMS: To evaluate clinicopathological characteristics of sporadic EOCRC (in patients < 50 years old) and investigate changes over time METHODS: All patients with sporadic EOCRC between 1...

Descripción completa

Detalles Bibliográficos
Autores principales: Vuik, Fanny E. R., Nieuwenburg, Stella A. V., Nagtegaal, Iris D., Kuipers, Ernst J., Spaander, Manon C. W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9292775/
https://www.ncbi.nlm.nih.gov/pubmed/34637541
http://dx.doi.org/10.1111/apt.16638
_version_ 1784749457706844160
author Vuik, Fanny E. R.
Nieuwenburg, Stella A. V.
Nagtegaal, Iris D.
Kuipers, Ernst J.
Spaander, Manon C. W.
author_facet Vuik, Fanny E. R.
Nieuwenburg, Stella A. V.
Nagtegaal, Iris D.
Kuipers, Ernst J.
Spaander, Manon C. W.
author_sort Vuik, Fanny E. R.
collection PubMed
description BACKGROUND: The rising incidence of early onset colorectal cancer (EOCRC) might reflect a novel tumour entity. AIMS: To evaluate clinicopathological characteristics of sporadic EOCRC (in patients < 50 years old) and investigate changes over time METHODS: All patients with sporadic EOCRC between 1989 and 2016 were included and divided by age: 20‐29 years (group I), 30‐39 years (group II) and 40‐49 years (group III). RESULTS: We included 6400 patients. The presence of signet‐ring cells and more poorly differentiated tumours were more common in the younger age groups: 5.4% and 3.7% for signet‐ring cells in group I and II vs 1.4% in group III (P < 0.01), and 28.5% and 20.3% for poorly differentiated in group I and II vs 16.6% in group III, (P < 0.01 group I; P = 0.07 group II). Positive lymph nodes were more frequently observed in the younger age groups: 16.2% in group I vs 9.3% in group II (P = 0.01) and 7.9% (P < 0.01) in group III. Over time, a greater proportion of CRCs were diagnosed in women in group I (34.5% < 2004 vs 54.9%>2005, P = 0.09), and a higher percentage of rectal cancer was found in age group III (34.3% < 2004 vs 40.7% > 2005, P < 0.01). Mean overall survival was 6.3 years and improved over time. CONCLUSIONS: EOCRC is not only characterised by age of onset but also by the more frequent presence of signet‐ring cells, more poorly differentiated tumours, and higher risk of lymph node metastases. In the most recent years, a higher proportion of rectal cancer was found from the age of 30 years, and a higher proportion of CRCs were diagnosed in females below the age of 30 years.
format Online
Article
Text
id pubmed-9292775
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-92927752022-07-20 Clinicopathological characteristics of early onset colorectal cancer Vuik, Fanny E. R. Nieuwenburg, Stella A. V. Nagtegaal, Iris D. Kuipers, Ernst J. Spaander, Manon C. W. Aliment Pharmacol Ther Early Onset Colorectal Cancer BACKGROUND: The rising incidence of early onset colorectal cancer (EOCRC) might reflect a novel tumour entity. AIMS: To evaluate clinicopathological characteristics of sporadic EOCRC (in patients < 50 years old) and investigate changes over time METHODS: All patients with sporadic EOCRC between 1989 and 2016 were included and divided by age: 20‐29 years (group I), 30‐39 years (group II) and 40‐49 years (group III). RESULTS: We included 6400 patients. The presence of signet‐ring cells and more poorly differentiated tumours were more common in the younger age groups: 5.4% and 3.7% for signet‐ring cells in group I and II vs 1.4% in group III (P < 0.01), and 28.5% and 20.3% for poorly differentiated in group I and II vs 16.6% in group III, (P < 0.01 group I; P = 0.07 group II). Positive lymph nodes were more frequently observed in the younger age groups: 16.2% in group I vs 9.3% in group II (P = 0.01) and 7.9% (P < 0.01) in group III. Over time, a greater proportion of CRCs were diagnosed in women in group I (34.5% < 2004 vs 54.9%>2005, P = 0.09), and a higher percentage of rectal cancer was found in age group III (34.3% < 2004 vs 40.7% > 2005, P < 0.01). Mean overall survival was 6.3 years and improved over time. CONCLUSIONS: EOCRC is not only characterised by age of onset but also by the more frequent presence of signet‐ring cells, more poorly differentiated tumours, and higher risk of lymph node metastases. In the most recent years, a higher proportion of rectal cancer was found from the age of 30 years, and a higher proportion of CRCs were diagnosed in females below the age of 30 years. John Wiley and Sons Inc. 2021-10-12 2021-12 /pmc/articles/PMC9292775/ /pubmed/34637541 http://dx.doi.org/10.1111/apt.16638 Text en © 2021 The Authors. Alimentary Pharmacology & Therapeutics published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Early Onset Colorectal Cancer
Vuik, Fanny E. R.
Nieuwenburg, Stella A. V.
Nagtegaal, Iris D.
Kuipers, Ernst J.
Spaander, Manon C. W.
Clinicopathological characteristics of early onset colorectal cancer
title Clinicopathological characteristics of early onset colorectal cancer
title_full Clinicopathological characteristics of early onset colorectal cancer
title_fullStr Clinicopathological characteristics of early onset colorectal cancer
title_full_unstemmed Clinicopathological characteristics of early onset colorectal cancer
title_short Clinicopathological characteristics of early onset colorectal cancer
title_sort clinicopathological characteristics of early onset colorectal cancer
topic Early Onset Colorectal Cancer
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9292775/
https://www.ncbi.nlm.nih.gov/pubmed/34637541
http://dx.doi.org/10.1111/apt.16638
work_keys_str_mv AT vuikfannyer clinicopathologicalcharacteristicsofearlyonsetcolorectalcancer
AT nieuwenburgstellaav clinicopathologicalcharacteristicsofearlyonsetcolorectalcancer
AT nagtegaalirisd clinicopathologicalcharacteristicsofearlyonsetcolorectalcancer
AT kuipersernstj clinicopathologicalcharacteristicsofearlyonsetcolorectalcancer
AT spaandermanoncw clinicopathologicalcharacteristicsofearlyonsetcolorectalcancer